Advertisement
Screener

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) Operating Lease, Liability, Current

2.8 / 5 stars · 68/120 Roast Me

NATURE’S SUNSHINE PRODUCTS, INC. Operating Lease, Liability, Current

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Operating Lease, Liability, Current of $4.42 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Leases

us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06

  • 2026-06-30: Operating Lease, Liability, Current $4.42M.
  • 2026-03-31: Operating Lease, Liability, Current $4.37M.
  • 2025-12-31: Operating Lease, Liability, Current $3.27M.
  • 2025-09-30: Operating Lease, Liability, Current $4.60M.
Period endOperating Lease, Liability, Current
2026-06-30$4.42M
10-Q · filed 2026-08-06
2026-03-31$4.37M
10-Q · filed 2026-05-07
2025-12-31$3.27M
10-Q · filed 2026-08-06
2025-09-30$4.60M
10-Q · filed 2025-11-06
2025-06-30$4.63M
10-Q · filed 2025-07-31
2025-03-31$4.29M
10-Q · filed 2025-05-06
2024-12-31$3.93M
10-K · filed 2026-03-10
2024-09-30$4.04M
10-Q · filed 2024-11-07
2024-06-30$3.96M
10-Q · filed 2024-08-08
2024-03-31$5.06M
10-Q · filed 2024-05-07
2023-12-31$4.55M
10-K · filed 2025-03-11
2023-09-30$4.50M
10-Q · filed 2023-11-07
2023-06-30$4.67M
10-Q · filed 2023-08-09
2023-03-31$4.67M
10-Q · filed 2023-05-09
2022-12-31$4.27M
10-K · filed 2024-03-12
2022-09-30$4.07M
10-Q · filed 2022-11-03
2022-06-30$4.34M
10-Q · filed 2022-08-09
2022-03-31$4.54M
10-Q · filed 2022-05-05
2021-12-31$4.35M
10-K · filed 2023-03-16
2021-09-30$4.50M
10-Q · filed 2021-11-04
2021-06-30$4.47M
10-Q · filed 2021-08-05
2021-03-31$4.63M
10-Q · filed 2021-05-06
2020-12-31$4.99M
10-K · filed 2022-03-08
2020-09-30$4.96M
10-Q · filed 2020-11-09
2020-06-30$4.42M
10-Q · filed 2020-08-06
2020-03-31$4.50M
10-Q · filed 2020-05-11
2019-12-31$4.94M
10-K · filed 2021-03-10
2019-09-30$5.05M
10-Q · filed 2019-11-07
2019-06-30$5.24M
10-Q · filed 2019-08-09
2019-03-31$4.09M
10-Q · filed 2019-05-09
2019-01-01$4.43M
10-K · filed 2020-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01